Key terms
About BIOR
Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BIOR news
Apr 09
6:17am ET
Biora Therapeutics Receives Buy Rating Amid Positive Clinical Progress and Promising Drug Delivery Innovations
Apr 08
4:12pm ET
Biora Therapeutics files to sell 10.7M shares of common stock for holders
Apr 08
8:32am ET
Biora Therapeutics announces patent covering BioJet liquid jet delivery tech
Apr 04
8:18am ET
Biora Therapeutics announces interim results of BT-600 clinical trial
Apr 01
8:16am ET
Biora Therapeutics prices 5.45M shares at $1.10 in registered direct offering
Mar 26
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 26, 2024
Mar 25
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
Mar 11
8:23am ET
Biora Therapeutics enters investment agreement with Context Capital
Mar 11
8:22am ET
Biora Therapeutics Restructures Debt, Monetizes Assets for Growth
Feb 26
8:07am ET
Biora Therapeutics completes SAD cohorts of Phase 1 trial of BT-600
No recent press releases are available for BIOR
BIOR Financials
Key terms
Ad Feedback
BIOR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BIOR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
